Yaron Weber
Stock Analyst at TD Cowen
(2.21)
# 2,854
Out of 5,147 analysts
9
Total ratings
55.56%
Success rate
8.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Weber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Reiterates: Buy | $325 | $233.50 | +39.19% | 1 | Jan 7, 2026 | |
| ZYME Zymeworks | Initiates: Buy | n/a | $23.29 | - | 1 | May 20, 2025 | |
| AMGN Amgen | Maintains: Buy | $381 → $383 | $388.16 | -1.33% | 5 | Oct 21, 2024 | |
| NUVB Nuvation Bio | Initiates: Outperform | n/a | $5.91 | - | 1 | Mar 8, 2021 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $684 → $565 | $781.67 | -27.72% | 1 | Feb 8, 2021 |
Ascendis Pharma
Jan 7, 2026
Reiterates: Buy
Price Target: $325
Current: $233.50
Upside: +39.19%
Zymeworks
May 20, 2025
Initiates: Buy
Price Target: n/a
Current: $23.29
Upside: -
Amgen
Oct 21, 2024
Maintains: Buy
Price Target: $381 → $383
Current: $388.16
Upside: -1.33%
Nuvation Bio
Mar 8, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.91
Upside: -
Regeneron Pharmaceuticals
Feb 8, 2021
Maintains: Outperform
Price Target: $684 → $565
Current: $781.67
Upside: -27.72%